TAXES - Reconciliation (Details) - USD ($) |
6 Months Ended | |
|---|---|---|
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Income Tax Amount Reconciliation | ||
| Income tax (benefit) expense at PRC statutory income tax rate | $ (1,511,409) | $ (1,248,207) |
| Tax Jurisdiction of Domicile [Extensible Enumeration] | CHINA | CHINA |
| Impact of different tax rates in other jurisdictions | $ 1,124,292 | $ 840,758 |
| Effect of preferential tax rate | 250,663 | 259,890 |
| Super deduction of qualified R&D expenditures | (4,788) | (8,597) |
| Effect of change in valuation allowance | 51,591 | 50,437 |
| Non-deductible items and other | 5,305 | 7,062 |
| Total income tax benefit | $ (84,347) | $ (98,657) |
| Qualified R&D Expenditures of PRC Deduction Percentage | 100.00% | |
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to deduction for qualified research and development expenditure. No definition available.
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to non-deductible items and other adjustments. No definition available.
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to effect of preferential tax rates. No definition available.
|
| X | ||||||||||
- Definition The percentage of qualified research and development expenditures allowed as deduction as per the income tax law of the respective jurisdiction during the reporting period. No definition available.
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit). Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Indicates tax jurisdiction of domicile. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|